Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 10,739 | 1,764 | 1,574 | 1,339 | 1,726 |
| Gross Profit | 10,739 | 1,764 | 1,574 | 1,339 | 1,726 |
| Operating Expenses | 9,251 | 27,463 | 15,507 | 22,779 | 23,309 |
| Operating Income | 1,488 | -25,699 | -13,933 | -21,440 | -21,583 |
| Interest Expense | 28 | 28 | 30 | 29 | 34 |
| Other Income | 1,063 | 1,201 | 1,431 | 1,752 | 1,821 |
| Pre-tax Income | 2,523 | -24,526 | -12,532 | -19,717 | -19,796 |
| Net Income Continuous | 2,523 | -24,526 | -12,532 | -19,717 | -19,796 |
| Net Income | $2,523 | $-24,526 | $-12,532 | $-19,717 | $-19,796 |
| EPS Basic Total Ops | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 |
| EPS Basic Continuous Ops | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 |
| EPS Diluted Total Ops | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 |
| EPS Diluted Continuous Ops | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 |
| EBITDA(a) | $1,499 | $-25,369 | $-13,600 | $-21,104 | $-21,227 |